<DOC>
	<DOCNO>NCT02198287</DOCNO>
	<brief_summary>Safety , tolerability pharmacokinetic study BIIX 1 XX healthy male volunteer .</brief_summary>
	<brief_title>Dose Extension Study BIIX 1 XX Healthy Young Male Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy male , base complete medical examination Age range 21 50 year Participant must within +/ 20 % normal weight ( BrocaIndex ) Participant must provide write informed consent Any finding medical examination ( include blood pressure , pulse rate electrocardiogram ) laboratory test deviate normal clinical relevance Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Diseases central nervous system ( epilepsy ) psychiatric disorder History orthostatic hypotension , faint spell blackouts Chronic relevant acute infection History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator Intake drug long halflife ( â‰¥ 24 hour ) within least one month le halflives respective drug enrolment study Use drug might influence result trial within seven day prior administration trial Participation another trial investigational drug within two month prior start study Smoker ( &gt; 10 cigarette 3 cigar 3 pipes/day ) Inability refrain smoke study day Alcohol abuse Drug abuse Blood donation ( &gt; 100 ml ) within four week prior administration Other disease abnormality clinical relevance Excessive physical activity within two week prior administration trial</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>